Home
AbbVie

AbbVie Market Share Analysis for March 2026

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74, and rank 89 on the 2024 list.

Industry: N/A

Domainabbvie.com.hk

Year Founded2013

Employees> 10001

Annual Revenue> $1B

AbbVie

AbbVie (including company regionals)

abbvie.com.hk

See more website traffic and engagement information

AbbVie Revenue up to March 2026 is > 1B

revenue generated by AbbVie top domains

AbbVie top domains revenue over 3 years

Revenue for AbbVie top domains

abbvie.com.hk> 1B

See more with Sales Intelligence

AbbVie Stock price in March 2026

AbbVie stock is traded under the ticker #ABBV. Below you can review AbbVie stock performance in the past 12 months up to March 2026

Total visits to AbbVie's top domains

Understand AbbVie market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

abbvie.com.hk1.3K

See more with Sales Intelligence

Avg. visit duration in AbbVie's top domains

Analyze AbbVie engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

abbvie.com.hk00:02:34

See more with Sales Intelligence

Avg. pageviews on AbbVie's top domains

See how AbbVie keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

abbvie.com.hk2.21

See more with Sales Intelligence

AbbVie top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by AbbVie

These are the website technologies, by industry, used by AbbVie top domains

Audio Video Media (2)

YouTube

Advertising (1)

DoubleClick

Content Management System (1)

Adobe Experience Manager

Conversion & Analytics (1)

Google Analytics

More Technologies

4

See all

News & Signals from AbbVie

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAbbVie Inc. is developing Jacobio's SHP2 portfolio on Jun 1st '20.Financial details of the deal were not disclosed back in June 2020 when it was originally signed, but AbbVie snagged an exclusive license to develop Jacobio's SHP2 portfolio.

NewsJacobiopharma partnered with AbbVie Inc. on Jul 4th '23.China-headquartered Jacobio has announced the termination of a deal (PDF) with AbbVie that involved global development and commercialization of SHP2 inhibitors including solid tumor med JAB-3312, according to a regulatory document dated July 4.

NewsAbbVie Inc. files suit against BeiGene Ltd..And AbbVie has filed a suit in the U.S. against BeiGene, one of China’s most up-and-coming young drug makers.